Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies
Lucas Silva Rodrigues, Giordano Novak Rossi, Juliana Mendes Rocha, et al.
European Archives of Psychiatry and Clinical Neuroscience (2021) Vol. 272, Iss. 4, pp. 541-556
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey
José Carlos Bouso, Óscar Andión, Jerome Sarris, et al.
PLOS Global Public Health (2022) Vol. 2, Iss. 11, pp. e0000438-e0000438
Open Access | Times Cited: 69
Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 28
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16
Opioid use disorder: current trends and potential treatments
Yu Kyung Lee, Mark S. Gold, Kenneth Blum, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 14
Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions
Kenji Hashimoto, Mingming Zhao, Tingting Zhu, et al.
Journal of Anesthesia and Translational Medicine (2024) Vol. 3, Iss. 3, pp. 65-75
Open Access | Times Cited: 11
N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine
Edward James, Joachim Keppler, Thomas L Robertshaw, et al.
Human Psychopharmacology Clinical and Experimental (2022) Vol. 37, Iss. 3
Open Access | Times Cited: 30
Ayahuasca's therapeutic potential: What we know – and what not
Lucas Oliveira Maia, Dimitri Daldegan‐Bueno, Isabel Wießner, et al.
European Neuropsychopharmacology (2022) Vol. 66, pp. 45-61
Closed Access | Times Cited: 28
Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study
Daniel Perkins, Broc A. Pagni, Jerome Sarris, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
Effects of psychedelics on opioid use disorder: a scoping review of preclinical studies
Alejandra Pulido-Saavedra, Henrique Nunes Pereira Oliva, Tiago Paiva Prudente, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Vermont Primary Care Provider Perspectives on Psychedelics — A Cross-Sectional Study
Josephine Yalovitser, jonah levine, Cole Zweber, et al.
Journal of Psychoactive Drugs (2025), pp. 1-7
Closed Access
The current state of ayahuasca research in animal models: A systematic review
Dimitri Daldegan‐Bueno, Natália Maria Simionato, Vanessa Manchim Favaro, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 125, pp. 110738-110738
Open Access | Times Cited: 11
Targeting Opioid Receptors in Addiction and Drug Withdrawal: Where Are We Going?
Rita Tabanelli, Simone Brogi, Vincenzo Calderone
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10888-10888
Open Access | Times Cited: 11
Long-term ayahuasca use is associated with preserved global cognitive function and improved memory: a cross-sectional study with ritual users
Arilton Martins Fonseca, Rafael G. dos Santos, Lívia Soman de Medeiros, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Closed Access | Times Cited: 4
Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant
Giordano Novak Rossi, Lorena T. L. Guerra, Glen B. Baker, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1618-1618
Open Access | Times Cited: 17
Indigenous-Amazonian Traditional Medicine’s Usage of the Tobacco Plant: A Transdisciplinary Ethnopsychological Mixed-Methods Case Study
Ilana Berlowitz, Ernesto García Torres, Caroline Maake, et al.
Plants (2023) Vol. 12, Iss. 2, pp. 346-346
Open Access | Times Cited: 9
Phytopharmacological aspects of Mimosa tenuiflora (Willd.) poir.: a systematic review of preclinical data
Emerson de Oliveira Silva, Myla Lôbo de Souza, Nathália Andrezza Carvalho de Souza, et al.
Phytochemistry Reviews (2024) Vol. 23, Iss. 4, pp. 1183-1203
Closed Access | Times Cited: 3
From taboo to treatment: The emergence of psychedelics in the management of pain and opioid use disorder
Jeremy Weleff, Julio C. Nunes, Gabriel P. A. Costa, et al.
British Journal of Clinical Pharmacology (2024)
Open Access | Times Cited: 3
Teacher plants — Indigenous Peruvian-Amazonian dietary practices as a method for using psychoactives
Ilana Berlowitz, David M. O’Shaughnessy, Michael Heinrich, et al.
Journal of Ethnopharmacology (2021) Vol. 286, pp. 114910-114910
Open Access | Times Cited: 19
Looking beyond the opioid receptor: A desperate need for new treatments for opioid use disorder
Yu Kyung Lee, Mark S. Gold, Brian Fuehrlein
Journal of the Neurological Sciences (2021) Vol. 432, pp. 120094-120094
Closed Access | Times Cited: 16
Psychosocial and Drug Use Assessment of Regular vs. Non-Regular Ayahuasca Users in a Brazilian Sample: a Web-Based Survey
Dimitri Daldegan‐Bueno, Dóra Révész, Paulo Rogério Morais, et al.
Substance Use & Misuse (2022) Vol. 57, Iss. 7, pp. 1072-1081
Closed Access | Times Cited: 11
Insights, Life Changes and Lifestyle Changes Reported by Individuals Consuming Ayahuasca in Naturalistic Settings: Nature, Frequency and Associations with Mental Health and Wellbeing
Daniel Perkins, Emérita Sátiro Opaleye, José Carlos Bouso, et al.
Psychoactives (2023) Vol. 2, Iss. 4, pp. 256-286
Open Access | Times Cited: 6
Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature
Alessio Mosca, Stefania Chiappini, Andrea Miuli, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 11, pp. 2178-2194
Open Access | Times Cited: 10
Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health
Julián Urrutia, B. Anderson, Sean J. Belouin, et al.
Journal of Psychoactive Drugs (2023) Vol. 55, Iss. 5, pp. 523-538
Open Access | Times Cited: 5
Self-Rated Effectiveness of Ayahuasca and Breathwork on Well-Being, Psychological Resilience, Self-Compassion, and Personality: An Observational Comparison Study
Rishma S. I. Khubsing, Martin van Leerdam, Eline Haijen, et al.
Psychoactives (2024) Vol. 3, Iss. 2, pp. 167-183
Open Access | Times Cited: 1
Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges
Anton Gomez-Escolar, Daniel Folch-Sanchez, Joanna Stefaniuk, et al.
CNS Drugs (2024) Vol. 38, Iss. 10, pp. 771-789
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top